The global smart insulin pens market is valued at USD 4.31 billion in 2024 and is poised to reach USD 10.36 billion by 2035, representing a CAGR of 8.30% during the forecast period. On the basis of geographical regions, the global smart insulin pens market value is distributed across North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America. According to our market analysis, presently North America holds the highest share (35%) of the market, driven by the growing case...

The global DNA read, write and edit market is expected to increase from USD 8.33 billion in 2025 to USD 29.78 billion by 2035, representing a CAGR of 13.6% during the forecast period. Presently, the key players of the industry are focusing on the development of next generation genome sequencing technologies that aid in editing genes precisely with higher accuracy rate. For instance, in October 2024, Illumina launched the MiSeq

The manufacturing execution system market, valued at USD 4.62 billion in 2025, is projected to grow to USD 5.36 billion in 2026 and USD 20.46 billion by 2035, representing a CAGR of 16.0% during the forecast period. In recent years, with the mounting penetration of technological advancements, the market for manufacturing execution systems has been evolving exponentially. The trend of integrated quality management systems is one of the latest trends in the manufacturing execution system industry....

The global automated suturing devices market is estimated to grow from 3.40 billion in 2024 to USD 6.60 billion by 2035, at a CAGR of 6.20% during the forecast period, till 2035. The global market is propelled by various factors such as growing demand for minimally invasive treatment and rising risk of chronic conditions. A recent report of Centers for Disease Control and Prevention stated that, nearly 129 million people in United States are suffering from at least one chronic disease. Therefore...

The global amyotrophic lateral sclerosis market size is valued at USD 0.79 billion in 2024 and is estimated to reach USD 1.38 billion by 2035, representing a CAGR of 5.2% during the forecast period. It is important to highlight here that in May 2024, European Medicines Agency (EMA) approved Biogen

The Asia-Pacific women's digital health market is estimated to grow at a CAGR of 19.3% during the forecast period. The market is likely to cross USD 3,770 million by 2035. As per the recent report of the Asia-Pacific Resource and Research Center for Women, every year nearly 265,884 Asian women are diagnosed with cervical cancer, and around 42,735 deaths have been reported from the disease. Considering the necessity of maintaining female reproductive, fertility and general health, various FemTech...

The Europe women's digital health market is valued at USD 0.73 billion in 2024 and this value is anticipated to reach USD 4.8 billion by 2035. The market has been projected to grow at a compounded annual growth rate (CAGR) of 17.9% during the forecast period. The opportunity in Europe women

The global meditation market size is estimated to grow from USD 8.87 billion in 2025 to USD 37.53 billion by 2035, representing a CAGR of 15.52% during the forecast period. In November 2024, Headspace announced the collaboration with World of Hyatt, in order to offer five-episode video series for the latter

The multiomics market size is projected to grow from USD 3.10 billion in 2025 to USD 12.65 billion by 2035, representing a CAGR of 15.09% during the forecast period till 2035. Biomedical firms and emerging drug discovery companies are investing in the industry to leverage the technology. For instance, in May 2024, MultiOmic Health raised $6.2 million in a seed funding extension to develop its precision therapeutic platform for metabolic syndrome-related conditions. The funding was led by Hoxton...

The global biologics market size is worth around $411 billion in 2024 and is expected to reach $962 billion by 2035, representing a higher compounded annual growth rate (CAGR) of 8.04% during the forecast period. According to the World Health Organization report, nearly 422 million people across the globe are suffering from diabetes. Moreover, nearly 41 million people die annually due to non-communicable diseases, which is equivalent to around 74% of all deaths occurring across the globe. The ri...

The global monoclonal antibodies in veterinary health market is estimated to grow from USD 0.8 billion in 2024 to USD 4.3 billion by 2035, representing a higher CAGR of 17% during the forecast period. According to the report of the American Veterinary Medical Association, nearly 1 out of 4 dogs are estimated to have neoplasia (a form of cancer). The increasing incidence of cancer in companion animals, particularly in dogs, has underscored the requirement of advanced therapeutics to eradicate can...

The global medical tourism market size is estimated to grow from USD 33.78 billion in 2024 to USD 176.17 billion by 2035, representing a CAGR of 16.20% during the forecast period. Medical tourism is a common practice of traveling to different destinations and across international borders for healthcare facilities. With rising disposable income, medical insurance coverages and growing preferences for advanced healthcare services, medical tourism is booming across the globe. According to the recen...

The influenza vaccine market size is projected to grow from USD 8.27 billion in 2025 to USD 17.41 billion by 2035, representing a CAGR of 7.72% during the forecast period till 2035. Influenza, also known as flu, an acute respiratory infection spread by the influenza virus is a common viral infectious disease. According to WHO

The medical second opinion market size is projected to grow from USD 7.42 billion in 2025 to USD 29.44 billion by 2035, representing a CAGR of 14.77% during the forecast period till 2035. The distribution of the market for second opinion is divided into health insurance companies, hospitals, physicians, specialty clinics, and others. As per this medical second opinion market report, the hospital segment is expected to drive the market demand with (~41%) of the market share and will likely domina...

The atopic dermatitis market size is projected to grow from USD 13.69 billion in 2025 to USD 31.86 billion by 2035, representing a CAGR of 8.81% during the forecast period till 2035. According to an Oxford Academic report, nearly 2.6% of the population is affected by atopic dermatitis worldwide where children are more affected compared to adults,. This number exhibits a high prevalence of skin conditions similar to eczema that raise the atopic dermatitis market demand. Atopic dermatitis also kno...

The global thermoplastic elastomers market size is valued at USD 26.77 billion in 2024 and is poised to reach USD 47.25 billion by 2035, representing a higher CAGR of 5.30% during the forecast period. In November 2024, GEON Performance Solutions launched a new TPE manufacturing line in Mexico facility, in order to expand the production of thermoplastic elastomers and thermoplastic vulcanizate.

The medical exoskeleton market, valued at USD 1.41 billion in 2025, is projected to grow to USD 1.79 billion in 2026 and USD 8.70 billion by 2035, representing a CAGR of 19.2% during the forecast period. Medical exoskeletons are wearable robotic devices designed to assist individuals with mobility impairments. They use a combination of mechanical, electronic, and computer-controlled systems to support and enhance the user's movement, typically targeting specific body parts affected by injury or...

The global myasthenia gravis market is estimated to grow from USD 1.61 billion in 2024 to USD 3.13 billion by 2035, representing a compounded annual growth rate (CAGR) of 6.20% during the forecast period. As per the report of the Myasthenia Gravis Foundation of America, over 70,000 people in US have been diagnosed with myasthenia gravis, indicating a significant increase in the number of patients. It is important to highlight here that since 2017, the USFDA has approved several monoclonal antibo...

Over the last two decades, medical researchers have been able to achieve proof-of-concept and demonstrate the viability of benefits of mRNA-based interventions. In fact, currently, there are more than 65 mRNA-based therapeutics and over 85 mRNA vaccines under development. In vitro transcribed mRNA is now being evaluated as a treatment option for several oncological and genetic disorders. Moreover, experts believe that the applications of this upcoming product class are potentially limitless.